ArticleDiabetology & metabolic syndrome2025
Remnant cholesterol predicts the development of type 2 diabetes in patients with nonalcoholic fatty liver disease.
Article in Diabetology & metabolic syndrome, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A Narrative Review of Remnant Cholesterol as an Independent Atherogenic Lipoprotein in Type 2 Diabetes: Pathophysiology and Clinical Implications.Therapeutics and clinical risk management · 2026Review
- Remnant Cholesterol Inflammatory Index and New-Onset Diabetes in Middle-Aged and Older Adults: Evidence From Prospective Surveys of Chinese and UK Populations.Journal of diabetes research · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe predictive value of serum remnant cholesterol in cardiovascular disease has been widely recognized. This value has also been explored in metabolic disorders such as type 2 diabetes mellitus and nonalcoholic fatty liver disease (NAFLD). However, whether remnant cholesterol can predict the risk of incident diabetes in NAFLD patients remains unclear.
methodsThis study included adults who underwent health examinations from 2004 to 2015. NAFLD was diagnosed via abdominal ultrasonography with the exclusion of other causes of chronic liver disease. Cox proportional hazards regression analyses were performed to investigate the associations between baseline remnant cholesterol and diabetes risk in NAFLD patients and NAFLD-free participants.
resultsA total of 15,464 participants were included in this study, and 2,741 adults had NAFLD. During the 93,537 person-years of follow-up, 233 cases and 150 cases of incident diabetes were recorded among NAFLD patients and NAFLD-free individuals, respectively. Compared with the first quartile, the fourth quartile of remnant cholesterol was positively associated with the risk of diabetes in NAFLD patients (HR: 1.68, 95% CI: 1.13 - 2.51; P < 0.001). However, this association was not significant in NAFLD-free individuals.
conclusionsHigh remnant cholesterol was associated with an increased risk of incident diabetes in NAFLD patients but not in NAFLD-free individuals.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.